The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy

Author： Björn I.   Bixo M.   Nöjd K. S.   Collberg P.   Nyberg S.   Sundström-Poromaa I.   Bäckström T.  

Publisher： Informa Healthcare

ISSN： 1473-0766

Source： Gynecological Endocrinology, Vol.16, Iss.1, 2002-02, pp. : 1-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Medroxyprogesterone acetate exacerbates glutamate excitotoxicity

By Nilsen Jon   Morales Alison   Brinton Roberta  

Gynecological Endocrinology, Vol. 22, Iss. 7, 2006-07 ,pp. : 355-361

Informa Healthcare

Access to resources Recommend Favorite

Serotonergic Agents as an Alternative to Hormonal Therapy for the Treatment of Menopausal Vasomotor Symptoms

By Stearns Vered  

Treatments in Endocrinology, Vol. 5, Iss. 2, 2006-01 ,pp. : 83-87

Adis International

Access to resources Recommend Favorite

Effects of mifepristone on proliferation and apoptosis of human endometrium in new users of medroxyprogesterone acetate

By Jain John K.   Li Aimin   Yang Wangrong   Minoo Parviz   Felix Juan C.  

Human Reproduction, Vol. 21, Iss. 3, 2006-03 ,pp. : 798-809

Oxford University Press

Access to resources Recommend Favorite

Endometrial progesterone and estrogen receptors and bleeding disturbances in depot medroxyprogesterone acetate users

By Sereepapong Wisan  

Human Reproduction, Vol. 19, Iss. 3, 2004-03 ,pp. : 547-552

Oxford University Press

Access to resources Recommend Favorite

Comparative effects of dydrogesterone and medroxyprogesterone acetate in critical areas: The brain and the vessels

By Simoncini Tommaso   Mannella Paolo   Pluchino Nicola   Genazzani Andrea  

Gynecological Endocrinology, Vol. 23, Iss. 1, 2007-10 ,pp. : 9-16

Informa Healthcare

Access to resources Recommend Favorite